Market Research Industry Reports

Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. It focuses in the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and womens health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The companys drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets its products in the Middle East, Latin America, Africa and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 4
List of Figures 5
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Acino International AG, Medical Devices Deals, 2011 to YTD 2017 10
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Acino International AG, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 14
Private Equity 16
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 16
Partnerships 17
Litha Pharma Partners with Gland Pharma 17
Litha Pharma Partners with NTC 18
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 18
Litha Pharma Partners with Natco Pharma 19
Berlin Pharma Enters Into Co-Marketing Agreement With Acino Pharma 20
Licensing Agreements 21
Acino Pharma Extends its Licensing Agreement with AFT Pharma 21
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 22
Acino Holding Enters Into Licensing Agreement With Sawai Pharma 23
Acino Holding Enters Into Licensing Agreement With Novartis For Rivastigmine 23
Asset Transactions 24
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 24
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 25
Acquisition 26
Acino Pharma Acquires Litha Healthcare from Endo International 26
Acino Pharma Acquires Pharma Start 27
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 27
Litha Healthcare Acquires OTC Pharma South Africa 29
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 29
Acino International AG - Key Competitors 31
Key Employees 32
Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Corporate Communications 35
Apr 19, 2016: Appointment of Kalle Kand as CEO Acino Group 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Acino International AG, Deals By Therapy Area, 2011 to YTD 2017 9
Acino International AG, Medical Devices Deals, 2011 to YTD 2017 10
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 14
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 16
Litha Pharma Partners with Gland Pharma 17
Litha Pharma Partners with NTC 18
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 18
Litha Pharma Partners with Natco Pharma 19
Berlin Pharma Enters Into Co-Marketing Agreement With Acino Pharma 20
Acino Pharma Extends its Licensing Agreement with AFT Pharma 21
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 22
Acino Holding Enters Into Licensing Agreement With Sawai Pharma 23
Acino Holding Enters Into Licensing Agreement With Novartis For Rivastigmine 23
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 24
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 25
Acino Pharma Acquires Litha Healthcare from Endo International 26
Acino Pharma Acquires Pharma Start 27
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 27
Litha Healthcare Acquires OTC Pharma South Africa 29
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 29
Acino International AG, Key Competitors 31
Acino International AG, Key Employees 32
Acino International AG, Other Locations 33
Acino International AG, Subsidiaries 33

List Of Figures


Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Acino International AG, Medical Devices Deals, 2011 to YTD 2017 10

Acino International AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology

USD 250View Report

Acino International AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Acino International AG Company Profile is a detailed strategic and analytical report on Acino International AG. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Acino International AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology

USD 250View Report

Clariant International AG (CLN) - Financial and Strategic SWOT Analysis Review

Clariant International AG (CLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2017
No. of Pages :36
Country :Switzerland
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube